Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Danielle Moorman"'
Autor:
Januvi Jegatheswaran, Ryan Chan, Swapnil Hiremath, Danielle Moorman, Rita S. Suri, Tim Ramsay, Deborah Zimmerman
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Background: Frailty is a clinical phenotype of decreased physiologic reserve that is associated with increased morbidity and mortality. The most meaningful way to assess frailty in patients with end-stage kidney disease (ESKD) is unknown. Objective:
Externí odkaz:
https://doaj.org/article/33187f61d2be44f6a9bf942b50184f1a
Autor:
Danielle Moorman, Ranjeeta Mallick, Emily Rhodes, Brian Bieber, Gihad Nesrallah, Jan Davis, Rita Suri, Jeffery Perl, Peter Tanuseputro, Ronald Pisoni, Bruce Robinson, Manish M. Sood
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 6 (2019)
Background: Life expectancy in patients with end-stage kidney disease treated with hemodialysis (HD) is limited, and as such, the presence of an advanced care directive (ACD) may improve the quality of death as experienced for patients and families.
Externí odkaz:
https://doaj.org/article/bb70efbee1be4e30a1f1c3668363b8b3
Autor:
Danielle Moorman, Nathan G. Pilkey, Chloe J. Goss, Rachel M. Holden, Hasitha Welihinda, Claire Kennedy, Sandra M. Halliday, Christine A. White
Publikováno v:
Hemodialysis International. 26:461-479
Thrice weekly hemodialysis (HD) is currently the norm in high income countries but there is mounting interest in twice weekly HD in certain settings. We performed this systematic review to summarize the available evidence comparing twice to thrice we
Autor:
Gregory L Hundemer, Pietro Ravani, Manish M Sood, Deborah Zimmerman, Amber O Molnar, Danielle Moorman, Matthew J Oliver, Christine White, Swapnil Hiremath, Ayub Akbari
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
Background The transition from chronic kidney disease (CKD) to kidney failure is a vulnerable time for patients, with suboptimal transitions associated with increased morbidity and mortality. Whether social determinants of health are associated with
Autor:
Manish M. Sood, Ronald L. Pisoni, Rita S. Suri, Jeffery Perl, Brian Bieber, Emily Rhodes, Peter Tanuseputro, Ranjeeta Mallick, Bruce G. Robinson, Gihad Nesrallah, Danielle Moorman, Jan Davis
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 6 (2019)
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease
Life expectancy in patients with end-stage kidney disease treated with hemodialysis (HD) is limited, and as such, the presence of an advanced care directive (ACD) may improve the quality of death as experienced for patients and families. Strategies t
Publikováno v:
Journal of thrombosis and thrombolysis. 49(1)
Microangiopathic hemolytic anemia and thrombocytopenia (MAHA-T) is a rare complication of acute pancreatitis (AP). Treatment with therapeutic plasma exchange (TPE) is used at many centers. The natural history of this disease is not well understood. W
Autor:
Tim Ramsay, Deborah Zimmerman, Swapnil Hiremath, Januvi Jegatheswaran, Rita S. Suri, Ryan Chan, Danielle Moorman
Publikováno v:
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Canadian Journal of Kidney Health and Disease, Vol 7 (2020)
Frailty is a clinical phenotype of decreased physiologic reserve that is associated with increased morbidity and mortality. The most meaningful way to assess frailty in patients with end-stage kidney disease (ESKD) is unknown.To assess the prevalence
Autor:
Rita S. Suri, Januvi Jegatheswaran, Swapnil Hiremath, Deborah Zimmerman, Danielle Moorman, Ann Bugeja, Teerath Kumar
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 14(2)
Background and objectives Patients with ESKD are sedentary. When patient-identified barriers to exercise are addressed, recruitment and retention in exercise trials remain low, suggesting that the trial design may not resonate with them. Therefore, w
Autor:
Glaucia E. Callera, Alexey Gutsol, Augusto C. Montezano, Ying He, Rhian M. Touyz, Jose W. Correa, Tayze T. Antunes, Danielle Moorman, Aurelie Nguyen Dinh Cat, Kevin D. Burns, Ana M. Briones
Publikováno v:
Bioscience Reports
High doses of Ang II receptor (AT1R) blockers (ARBs) are renoprotective in diabetes. Underlying mechanisms remain unclear. We evaluated whether high/ultra-high doses of candesartan (ARB) up-regulate angiotensin-converting enzyme 2 (ACE2)/Ang II type